Literature DB >> 3606931

Influence of age, sex and body weight on the dapsone acetylation phenotype.

P A Philip, S L Gayed, H J Rogers, P Crome.   

Abstract

The acetylation of dapsone (DDS) was determined by estimation of the ratio of monoacetyldapsone (MADDS) to DDS concentrations in plasma following a single dose of DDS in 337 white British subjects (193 female; 144 male). The percentage of slow DDS acetylators in the whole group was 60.3%. There was no statistically significant difference in this proportion between 191 elderly subjects (age greater than 65 years) and 143 young subjects (age less than 30 years). Although there was a small (66.3%) but significant (P = 0.033) preponderance of slow acetylators in the young male group there was no difference in the distribution of acetylator phenotypes between the sexes among either the elderly group or in the whole population studied. No correlation was found between absolute body weight and MADDS/DDS ratios.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3606931      PMCID: PMC1386165          DOI: 10.1111/j.1365-2125.1987.tb03105.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

Review 1.  N-acetylation pharmacogenetics.

Authors:  W W Weber; D W Hein
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

2.  Acetylator phenotypes: effect of age.

Authors:  B Gachályi; A Vas; P Hajós; A Káldor
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Formal genetics of isoniazid metabolism in man.

Authors:  L Iselius; D A Evans
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

Review 4.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

5.  On the significance of host factors that affect drug disposition.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

6.  Undernourished adults and acetylation phenotype.

Authors:  R Arunkumar Shastri
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-04

Review 7.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

8.  Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.

Authors:  R A Cartwright; R W Glashan; H J Rogers; R A Ahmad; D Barham-Hall; E Higgins; M A Kahn
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

9.  A rapid method for determination of acetylation phenotype using dapsone.

Authors:  P A Philip; M S Roberts; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

Review 10.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

View more
  11 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

3.  Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer.

Authors:  Y Horai; K Fujita; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Acetylation and oxidation phenotypes in malignant lymphoma.

Authors:  P A Philip; H J Rogers; P G Harper
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Comparison of CYP1A2 and NAT2 phenotypes between black and white smokers.

Authors:  Joshua E Muscat; Brian Pittman; Wayne Kleinman; Philip Lazarus; Steven D Stellman; John P Richie
Journal:  Biochem Pharmacol       Date:  2008-07-25       Impact factor: 5.858

6.  N-acetylation phenotyping using dapsone in a Jordanian population.

Authors:  Y M Irshaid; H F al-Hadidi; M A Abuirjeie; N M Rawashdeh
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

7.  N-acetylation phenotyping with sulphadimidine in a Turkish population.

Authors:  A Bozkurt; N E Basci; S Kalan; M Tuncer; S O Kayaalp
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Biomonitoring of 4,4'-methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans.

Authors:  P Brunmark; M Bruze; S Skerfving; G Skarping
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

Review 9.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

10.  N-acetylation polymorphism of dapsone in a Japanese population.

Authors:  Y Horai; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.